Stock Code: 002433 stock abbreviation: Guangdong Taiantang Pharmaceutical Co.Ltd(002433) Announcement No.: 2022-012 Guangdong Taiantang Pharmaceutical Co.Ltd(002433)
Announcement of resolutions of the 20th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings held
The 20th meeting of the 5th board of supervisors of Guangdong Taiantang Pharmaceutical Co.Ltd(002433) (hereinafter referred to as “the company”) was held on February 15, 2022 in the conference room on the second floor of Qilin park by means of on-site voting and communication voting. The meeting notice was sent by e-mail, fax, delivery, telephone and other means on February 5, 2022. There are 3 supervisors who should attend the meeting and 3 supervisors who actually attend the meeting, which is in line with the quorum for convening the meeting of the board of supervisors. The meeting was presided over by Mr. Chen Yinsong, chairman of the board of supervisors. The convening, convening and voting procedures of this meeting comply with the provisions of the company law, the articles of association, the rules of procedure of the board of supervisors and other relevant laws, administrative regulations, departmental rules and normative documents, and the meeting is legal and effective.
2、 Deliberations of the meeting
(I) deliberated and passed the proposal on providing guarantee for kangaido
The board of supervisors believes that after the termination of the sale of major assets of the company, Guangdong kangaido Digital Health Technology Co., Ltd. (hereinafter referred to as “kangaido”) will become the holding subsidiary of the company. This guarantee is mainly to properly solve the liabilities of kangaido to Chengdu Medical cloud Technology Co., Ltd. and its related parties and meet the capital needs of its business development, The board of supervisors believes that the risk of providing guarantee for kangaido is controllable, and there is no damage to the interests of the company and shareholders, especially small and medium-sized shareholders. Therefore, we agree to this guarantee and submit it to the general meeting of shareholders of the company for deliberation.
Voting results: 3 in favor, 0 against and 0 abstention.
3、 Documents for future reference
Guangdong Taiantang Pharmaceutical Co.Ltd(002433) resolution of the 20th meeting of the Fifth Board of supervisors
It is hereby announced
Guangdong Taiantang Pharmaceutical Co.Ltd(002433) board of supervisors February 16, 2002
